Abstract
Background
Incidental thyroid abnormalities are increasingly detected in patients undergoing PET scans. The aim of this study was to review our experience with the management of PET detected thyroid incidentalomas in a large single institution series.
Methods
All PET scans performed from May 2003 to July 2005 were reviewed and patients with incidental thyroid abnormalities were identified. From this group, patients that underwent further investigation were analyzed. Data relating to PET scan findings, FNA diagnoses, operative details, and histopathology was reviewed.
Results
In 8,800 patients, 16,300 PET scans were performed of whom 263 patients (2.9% of patients and 1.6% of PET scans) had findings positive for thyroid abnormality. Thyroid malignancy was noted in 42% (24 patients) of the 57 patients that underwent FNA. In the group of 27 patients that were subjected to operative intervention, 74% (20 patients) were noted to have a malignant diagnosis. The final histopathology revealed primary thyroid carcinoma in all these 20 patients (19 patients with papillary carcinoma and one patient with primary thyroid lymphoma). The factors that correlated with an increased risk of malignancy were the presence of physical finding (p = 0.01) and focal (p < 0.01) or unilateral uptake (p < 0.01) on PET scan. The average SUV was not useful in differentiating benign (9.2) from malignant lesions (8.2, p = 0.7).
Conclusions
PET detected incidental thyroid abnormalities are rare. In patients with positive PET scan findings and suspicious features, the incidence of primary thyroid malignancy is very high. These patients warrant further investigation followed by possible operative intervention.
Similar content being viewed by others
References
Cohen MS, Arslan N, Dehdashti F, Doherty G, Lairmore TC, Brunt M, Moley JF. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 2001; 130(6):941–946
Chen YK, Ding HJ, Chen KT, et al. Prevalence and risk of cancer of focal thyroid incidentalomas identified by 18F-Fluorodeoxyglusocse positron emission tomography for cancer screening in healthy subjects. Anticancer Research 2005; 25: 1421–1426
Kim TY, Kim WB, Ryu JS, Gong G, Hong SJ, Shong YK. 18F-Fluorodeoxyglusocse uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentalomas. Laryngoscope 2005; 115:1074–1078
Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 2005; 46(5):752–757
Kang KW, Kim SK, Kang HS, et al. Prevalence and risk of cancer of focal thyroid incidentalomas identified by 18F-Fluorodeoxyglusocse positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endo & Met 2005; 88(9): 4100–4104
Van den Bruel A, Maes A, De Potter T, et al. Clinical relevance of thyroid fluorodeoxyglucose-Whole Body positron emission tomography incidentalomas. J Clin Endo & Met 2005; 87(4): 1517–1520
Shiga T, Tsukamoto E, Nakada K, et al. Comparison of (18) F-FDG, (131)I-Na, and (201)T1 in diagnosis of recurrent or metastatic thyroid carcinoma. J Nucl Med 2001; 42(3):414–419
Muros MA, Llamas-Elvira JM, Ramirez-Navarro A, et al. Utility of fluorine-18-fluorodeoxyglusocse positron emission tomography in differentiated thyroid carcinoma with negative radioiodine scans and elevated serum thyroglobulin levels. Am J Surg 2000; 179(6): 457–461
Ruiz Franco-Bauz JV, Borrego Dorado I, Gomez Camarero P, Rodriguez Rodriguez JR, Vazquez Albertino RJ, Navarro Gonzalez E, Astorga Jiminez R. F-18-fluorodeoxyglusocse positron emission tomography on patients with differentiated thyroid cancer who present elevated human serum thyroglobulin levels and negative I-131 whole body scan. Rev Esp Med Nucl 2005; 24(1): 5–13
de Groot JW, Links TP, Jager PL, Kahraman T, Plukker JT. Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer. Ann Surg Oncol 2004; 11(8): 786–794
Diehl M, Graichen S, Menzel C, Lindhorst E, Grunwald F. F-18 FDG PET in insular thyroid cancer. Clin Nucl Med 2003; 28(9): 728–731
Chen YK, Liu FY, Yen RF, Kao CH. Compare FDG-PET and Tc-99m tetrofosmin SPECT to detect metastatic thyroid carcinoma. Acad Radiol 2003; 10(8): 835–839
Erdi YE, Nehmeh SA, Mulnix T, Humm JL, Watson CC. PET performance measurements for an LSO-based combined PET/CT scanner using the National Electrical Manufacturers Association NU 2-2001 standard. J Nucl Med 2004; 45(5):813–821
Mawlawi O, Podoloff DA, Kohlmyer S, et al. Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes. J Nucl Med 2004; 45(10):1734–1742
Gordon BA, Flanagan FL, Dehdashti F. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations. Am J Roentgenol 1997; 169:1675
Shreve PD, Anzai Y, Wahk RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999; 19:61
Yasuda S, Shohtsu A, Ide M, et al. Chronic thyroiditis: diffuse uptake of FDG at PET. Radiology 1998; 207:775
Boerner AR, Voth I, Theissen P, et al. Glucose metabolism of the thyroid in Graves’ disease measured by F-18-fluoro-deoxyglusocse positron emission tomography. Thyroid 1998; 8:765
Hsu CH, Liu RS, Wu CH, Chen SM, Shih LS. Complementary role of 18F-fluorodeoxyglusocse positron emission tomography and 131I scan in the follow-up of post-therapy differentiated thyroid cancer. J Formos Med Assoc 2002; 101(7):459–467
Diehl M, Risse JH, Brandt-Mainz K, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study. Eur J Nucl Med 2001; 28(11):1671–1676
Mitchell J, Parangi S. The thyroid incidentalomas: an increasingly frequent consequence of radiologic imaging. Semim Ultrasound CT MRI 2005; 26:37–46
Kim EK, Park CS, Chung WY, et al. New Sonographic Criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR AM J Roentgenol 2002; 178:687–691
Tomimori EK, Camargo RY, Bisi H, Medeiros-Neto G. Combined ultrasonographic and cytological studies in the diagnosis of thyroid nodules. Biochimie 1999; 81:447–452
Dario Ramos C, Chisin R, Yeung HWD, Larson SM, Macapinlac HA. Incidental Focal Thyroid Uptake on FDG positron emission tomographic scans may represent a second primary tumor. Clin Nucl Med 2001; 26(3):193–197
Kresnik E, Gallowitsch HJ, Mikosch P, et al. Fluorine-18-fluorodeoxyglusocse positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery 2003; 133:294–299
Acknowledgments
The authors would like to thank Mithat Gonen, PhD, for his assistance in the statistical analysis of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Are, C., Hsu, J.F., Schoder, H. et al. FDG-PET Detected Thyroid Incidentalomas: Need for Further Investigation?. Ann Surg Oncol 14, 239–247 (2007). https://doi.org/10.1245/s10434-006-9181-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-006-9181-y